Neuroprotective Mechanisms of Resveratrol in Alzheimer’s Disease: Role of SIRT1
Open accessThe DOI matches its Crossref record; 169 of the 170 references it cites were found in a registry or an index.
Abstract
Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder of the cortex and hippocampus, which eventually leads to cognitive impairment. Although the etiology of AD remains unclear, the presence of β ‐amyloid (A β ) peptides in these learning and memory regions is a hallmark of AD. Therefore, the inhibition of A β peptide aggregation has been considered the primary therapeutic strategy for AD treatment. Many studies have shown that resveratrol has antioxidant, anti‐inflammatory, and neuroprotective properties and can decrease the toxicity and aggregation of A β peptides in the hippocampus of AD patients, promote neurogenesis, and prevent hippocampal damage. In addition, the antioxidant activity of resveratrol plays an important role in neuronal differentiation through the activation of silent information regulator‐1 (SIRT1). SIRT1 plays a vital role in the growth and differentiation of neurons and prevents the apoptotic death of these neurons by deacetylating and repressing p53 activity; however, the exact mechanisms remain unclear. Resveratrol also has anti‐inflammatory effects as it suppresses M1 microglia activation, which is involved in the initiation of neurodegeneration, and promotes Th2 responses by increasing anti‐inflammatory cytokines and SIRT1 expression. This review will focus on the antioxidant and anti‐inflammatory neuroprotective effects of resveratrol, specifically on its role in SIRT1 and the association with AD pathophysiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Main cellular routes proposed for the mechanisms of resveratrol in Alzheimer's disease. Modified from Ma et al. [72].](https://figures.cochat.ai/paper-figures/298b13e31ae74366bf246f40fc9ced35/neuroprotective-mechanisms-of-resveratrol-in-alzheimers-disease-role-of-sirt1-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Likewise, SIRT1 inhibits Aβ production and neuroinflammation and prevents neuronal apoptosis in AD models.414”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [414]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10
Donmez, G., Wang, D., Cohen, D. E., & Guarente, L. (2010) · Cell · doi:10.1016/j.cell.2010.06.020 · Cited by 432
RetractedMarwarha, G., Raza, S., Meiers, C., & Ghribi, O. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.015 · Cited by 107
RetractedSmall molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · cited 1×
“Some studies have reported that resveratrol is an activator of SIRT1 [27, 69], although further evidence shows that resveratrol is not a direct activator of SIRT1 [70], and that its role may be related to the activation of substrates of SIRT1 [71].”
BackgroundAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 7×
“Some neurodegenerative diseases, such as AD, are associated with oxidative stress and neuroinflammation, and proteins that are closely related to this neurological disorder (i.e., AMPK, SIRT1, and PGC-1α) can be modulated by resveratrol [152]; however, there are few clinical studies on resveratrol in AD patients.”
BackgroundInfluentialModulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750 · cited 1×
“vation and had strong neuroprotective effects [68, 155].”
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885 · cited 1×
“However, oxidative stress is also an important event in the pathogenesis of AD [89], as the generation and accumulation of ROS and reactive nitrogen species can accelerate fibrillization, increase the toxicity of Aβ, and promote neuronal death and neurodegeneration [90–93].”
BackgroundHIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.003 · Cited by 1,602 · cited 1×
“Thus, showing a dose-dependent effect, resveratrol was able to activate AMPK independently of SIRT1 [116].”
BackgroundResveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Park, S.-J., Ahmad, F., Philp, A., Baar, K., Williams, T., Luo, H., Ke, H., Rehmann, H., Taussig, R., Brown, A. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.017 · Cited by 1,349
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Cited by
Items 301–400 of 401
Contreras, L. A. R., Anaya-Esparza, L. M., Estrada, S. H., Hernández-Villaseñor, L. A., Jara, J. M. S., Hernández, L., Camargo-Hernández, G., & de Alba, A. F. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004132 · Cited by 3
Tng, T. J. W., Cheah, I. K.-M., Halliwell, B. B., & Lim, K. (2026) · Antioxidants · doi:10.3390/antiox15040519 · Cited by 5
Subramanian, A., Tamilanban, T., Abdullah, A. D. I., Chitra, V., Sekar, M., Swaminathan, G., Yadav, I., Manimaran, V., Rajakumari, V., & Subramaniyan, V. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.101956 · Cited by 3
“Further, the invitro cytotoxicity of the compound was found to be well within the desirable range compared to that of the parent molecule resveratrol, consistent with the reported works [22,26,27].”
The Role of Resveratrol in Alzheimer's Disease: A Comprehensive Review of Current Research
Kumar, S., Saha, S., Sharma, B., Singh, S., Shukla, P., Mukherjee, S., Agarwal, M., Singh, K., & Singh, T. (2023) · Current Functional Foods · doi:10.2174/0126668629269244231127071411 · Cited by 15
Effect of gold-conjugated resveratrol nanoparticles on glioma cells and its underlying mechanism
Liu, X., Guo, Z., Li, J., Wu, D., Liu, Z., Guan, C., Guan, Y., & Lu, X. (2024) · Bio-Medical Materials and Engineering · doi:10.3233/bme-230171 · Cited by 3
“It has also been found that Rsv could play a protective role in Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative diseases [12–14].”
Wang, W., Li, G., Liu, Z., Liu, Y., Xu, Y., & Chen, Y. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111400 · Cited by 4
Chiang, M., Nicol, C. J. B., Yang, Y., Chiang, T., & Yen, C. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.02.002 · Cited by 3
Nutraceuticals in central nervous system diseases: potential mechanisms of neuroprotection
Gupta, R. C., & Costa, L. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00001-x · Cited by 4
Antioxidant Nutraceuticals as Novel Neuroprotective Agents
Katiyar, P., Ghosh, S., Saini, S., Ghosh, C., Agrawal, H., Sircar, D., & Roy, P. (2022) · Wiley eBooks · doi:10.1002/9781119746843.ch8 · Cited by 5
Acetylresveratrol (AC-Res): An Evolving Frontier in Modulating Gene Expression
Panigrahy, U. P., Buchade, R. S., Subhadra, S., Anoop Kumar, N., Gunjal, S. D., Selvakumari, E., Pandey, N. K., & Wal, A. (2024) · Current Gene Therapy · doi:10.2174/0115665232291487240603093218 · Cited by 2
Rumman, M., & Khan, M. V. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107767 · Cited by 5
Stage-Dependent Function of Astrocytes in Alzheimer’s Disease: A Review
Azari, H. B., Babaei, P., & Nakhjiri, M. T. (2026) · Neuroscience Insights · doi:10.1177/26331055261422166 · Cited by 2
“140 141-143 For example, administration of natural compounds such as curcumin, 144,145 genistein, 146 resveratrol, 147,148 and other anti-oxidative phytochemicals has been shown to attenuate astro-cyte-mediated neuroinflammation and improve cognitive function in late-stage AD models, and to support…”
Yin, Z., Gong, G., & Yin, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1742885 · Cited by 2
Khodabandeh, H., Keshavarzi, S., Moradian, P., & Edalatmanesh, M. A. (2020) · The Neuroscience Journal of Shefaye Khatam · doi:10.29252/shefa.8.4.1 · Cited by 2
Therapeutic role of nutraceuticals in the management of brain disorders
Benmelouka, A. Y., Shah, M. A., Saleem, U., Elshanbary, A. A., Meshref, M. M., Shah, G. M., Alsharif, I., Althobaiti, N. A., & Alhasani, R. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824356-5.00012-6 · Cited by 2
Zhao, J., Ding, J., Wang, L., & Li, H. (2022) · Journal of Acupuncture and Tuina Science · doi:10.1007/s11726-022-1335-3 · Cited by 3
Preventive Role of Nutraceutical Agents Against Aging
Jayasree, R., Thangam, C., Kulanthaivel, L., & Subbaraj, G. K. (2023) · Springer eBooks · doi:10.1007/978-981-99-0534-8_18 · Cited by 3
Harnessing Antioxidants to Counter Oxidative Stress-Induced Apoptosis
Yiran, D., Jiayi, W., & Lifang, M. (2024) · Biochemistry · doi:10.5772/intechopen.1004460 · Cited by 4
Nutraceutical approaches for Autism Spectrum Disorder treatment
Dobrachinski, F., Ribeiro, K. A., Bezerra, I. C., da Silva, A. J., Pereira, C. M. M., Vellasques, K., Padilha, H. A., Haas, S. E., Ávila, D. S., & Gubert, P. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115653 · Cited by 3
“…[112], immuno-modulator [113], antimicrobial [114], anti-inflammatory [112,115], antidepressant [116,117], antioxidant [107], cardioprotective [107], anti-angiogenesis and anticancer [118,119], and neuroprotective [120, 121], through different mechanisms of action that are not fully elucidated.”
Rostagno, A. A., & Ghiso, J. A. (2025) · Antioxidants · doi:10.3390/antiox14070812 · Cited by 7
“…and dark chocolate, exhibits diverse biological functions including, among others, modulation of glucose metabolism and inflammation-associated paths, as well as regulation of the activity of different enzymes therefore influencing multiple signaling mechanisms and cellular processes [254,271,292].”
Wang, Y. L., Zhang, Y., Liu, T., & Cui, J. Y. (2021) · Human & Experimental Toxicology · doi:10.1177/0960327121997977 · Cited by 2
Effect of plant extracts against Alzheimer’s disease
Obulesu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95762-5.00001-1 · Cited by 3
Neuroprotective Role of Nutritional Supplementation in Athletes
Chawla, V., Mishra, S., Singh, V. J., & Chawla, P. A. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666211209144721 · Cited by 2
Sirtuins, Mitochondria and the Melatonergic Pathway in Alzheimer’s DiseasePreprint
Anderson, G., & Maes, M. H. J. (2020) · Preprints.org · doi:10.20944/preprints202002.0396.v1 · Cited by 1
Resveratrol Aerosol Inhalation Attenuates Ovalbumin (OVA)‐Induced Asthma in BALB/c Mouse Model
Shan, C., Wu, Y., Tang, L., Lin, Y., Ni, Z., Wang, X., Luo, X., & Miao, X. (2024) · Journal of Food Biochemistry · doi:10.1155/2024/5916534 · Cited by 1
Exploring the Effects of Natural Antioxidants in Neurodegenerative Diseases: A Comprehensive Review
-, S. G., -, S. S., & Ogale, S. (2024) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2024.v06i06.34161 · Cited by 1
“These effects contribute to improved neuronal function and survival[36].”
Wang, Y., Le, Y., Zhao, W., Lan, Y., Peng, X., Wu, J., Zhang, Q., Xu, Y., & Zhao, H. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70631 · Cited by 1
“Increasing evidence indicated the health benefits of RES are largely attributed to the activation of SIRT1 [17, 26, 27], which is a histone/protein deacetylase involved in cellular senescence, inflammation, and stress resistance [17].”
Treatment options for Alzheimer’s Disease: An overview of the amyloid, tau, and alternate hypotheses
Eroltu, K. (2023) · Journal of High School Science · doi:10.64336/001c.89250 · Cited by 1
Yan, X., Zuo, Q., Li, X., Liu, Y., Wang, L., Gan, L., He, H., Wen, S., Tang, H., Wang, H., et al. (2026) · Inflammation · doi:10.1007/s10753-025-02414-1 · Cited by 1
“Sirt1, a NAD-dependent deacetylase [14], is involved in neuroinflammatory responses, as shown by Hyperi - cin’s ability to reduce inflammation in HT22 neurons by activating the Sirt1-Wnt pathway [ 15 ].”
Phytomicronutrients in neurodegeneration: modulating microglial dynamics for neuroprotection
Adhikary, K., Prameela, G., Das, J., Ramzan, M., Ganguly, K., Datta, N., Banerjee, P., Barman, S., Sridhar, S. B., Taj, T., et al. (2026) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2025-0239 · Cited by 3
Kim, W. S., Choi, J., Kim, S.-S., Kim, J. H., Han, Y., Ahn, M. J., Oh, S., Lee, B., Cho, I., Choi, C. W., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119019 · Cited by 1
Al-Dhahi, A. S., Al‐kuraishy, H. M., Fawzy, M. N., & Batiha, G. E. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111925 · Cited by 1
Nutritional and Botanical Approaches for Cognitive Health—Part 2
Lucius, K. (2019) · Alternative and Complementary Therapies · doi:10.1089/act.2019.29242.klu · Cited by 1
“29 As discussed in Part I of this review, sirtuin-1 acts to protect neurons through several mechanisms, including through the reduction of oxidative stress and reactive oxygen species, a curtailing of apoptosis, and promotion of cellular survival.”
Petrenko, V. I., Shevandova, A. A., Kubyshkin, A. V., Фомочкина, И. И., Shramko, Y. I., Makalish, T. P., Ogay, Y. A., & Хусаинов, Д. Р. (2021) · Medical news of the North Caucasus · doi:10.14300/mnnc.2021.16043 · Cited by 1
Neural Circuits and Some New Factors Involved in Hippocampal Memory
Jing, R., Cai, Q., Li, W., & Zhang, X. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101309 · Cited by 2
Drug discovery in Alzheimer’s disease by regulating autophagy
Hamano, T., & Endo, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89906-2.00002-2 · Cited by 1
Bharadwaj, S., Deore, T., & Mali, A. (2023) · International Journal of Herbal Medicine · doi:10.22271/flora.2023.v11.i5a.887 · Cited by 1
Ye, Y., Chen, Z., Shen, Y., Wu, H., Xu, R.-A., & Zhou, C.-J. (2024) · ACS Omega · doi:10.1021/acsomega.4c07752 · Cited by 1
The pathophysiological signaling and efficacy of medicinal herbal compounds in Alzheimer’s disease
Darabi, S., Ariaei, A., Gorgich, E. A. C., Rezaei, S., Behruzi, M., Abasian, Z., & Rustamzadeh, A. (2025) · Physiology and Pharmacology · doi:10.61186/phypha.29.1.3 · Cited by 1
Bhattacharjee, B., Shakya, A., Shivavedi, N., Sahu, R. K., & Sandhanam, K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.05.302 · Cited by 1
Sánchez-Melgar, A., Izquierdo-Ramírez, P. J., Palomera‐Ávalos, V., Pallàs, M., Albasanz, J. L., & Martín, M. (2021) · Nutrients · doi:10.3390/nu13093040 · Cited by 1
“Another molecule able to modulate adenosinergic signaling [32,33] is resveratrol (RSV), a plant-derived nutraceutical found in peanuts, berries, grapes, and red wines with proven beneficial properties for different pathologies, including metabolic [34,35] and neurodegenerative diseases [36,37].”
BackgroundNanotechnological Applications in the Diagnosis and Treatment of Alzheimer’s Dementia
Singh, P. N. D., Mishra, G., Pottoo, F. H., Zeleke, M. M., & Ewunetei, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_22 · Cited by 1
Sirtuins, mitochondria, and the melatonergic pathway in Alzheimer’s disease
Anderson, G., & Maes, M. H. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814118-2.00015-x · Cited by 1
The role of epigenetic modifications in Alzheimer’s disease
., S., & Wirawan, C. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20205860
“The neuroprotective mechanism in resveratrol has been linked with SIRT1 activation.(48)”
BackgroundKoh, H. S., Jang, H. J., Tae, S., Lee, M.-S., Min, J.-W., Mun, H.-J., Lee, J. N., Lee, H. J., Kim, D. H., Cho, H.-J., et al. (2020) · doi:10.21203/rs.3.rs-19583/v1
“SIRT1 also affects expression of pro-in ammatory cytokines by regulation of NF-κB expression in AD [19].”
BackgroundSirtuins in mechanistic target of rapamycin complex 1 signaling
Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814118-2.00012-4
Pukhalskaia, A. E., Linkova, N. S., Diatlova, A., Kozlov, K. L., Kvetnoy, I. M., Королева, М. В., & Am, V. (2021) · Advances in Gerontology · doi:10.1134/s2079057021020120
“The pathophysiology of neurodegenerative diseases, including AD, is associated with oxidative stress and an increased synthesis of reactive oxygen species (ROS), which lead to neuronal damage and impairment of neuroplasticity [4, 5].”
BackgroundSultana, A., & Alauddin, M. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101611 · Cited by 1
Koh, H. S., Jang, H. J., Tae, S., Lee, M.-S., Min, J.-W., Mun, H.-J., Lee, J. N., Lee, H. J., Dae Hoon, K. I. M., Cho, H., et al. (2020) · doi:10.21203/rs.3.rs-21918/v1
Modulation by SIRT1-mTORC1 Pathway Microglia Pruning Retinal Ganglion Cell DendritesPreprint
Yao, K., Mou, Q., Lou, X., Ye, M., Zhao, B., Hu, Y., Luo, J., Zhang, H., Li, X., & Zhao, Y. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4097123
Influência do resveratrol no tratamento da doença de Alzheimer: uma revisão da literatura
Silva, J. D. S., Rodrigues, J. R. P., de Oliveira, M. B. M., da Silva, S. M., Souza, K. S., da Silva, M. R. F., de Araújo, L. C. A., Pereira, E. S., Bezerra, A. Â., Ferreira, G. D. S., et al. (2022) · Research Society and Development · doi:10.33448/rsd-v11i11.33679 · Cited by 1
Self-citationProtective effects of resveratrol on nerves in rats with Alzheimer?s disease
Li, J., Yuan, C., & Hu, X. (2023) · ScienceAsia · doi:10.2306/scienceasia1513-1874.2023.020
Mechanism of Action of Phytonutrients on Alzheimer’s Disease
丁, 洁. (2023) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2023.132012
Neuroprotective Properties of Nutraceuticals in Regulating Neurodegenerative Dementia
Mazlan, N. A. (2023) · International Journal of Pharmaceuticals Nutraceuticals and Cosmetic Science · doi:10.24191/ijpnacs.v5i2.03
Genetic modulators of neurodegenerative diseases and their amelioration by natural products
Hameed, R., Naseer, A., Toppo, P., Akbar, M., Yadav, S., & Nazir, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19084-1.00019-3 · Cited by 1
Simon, P. Y. R., Bus, J., & David, R. (2023) · médecine/sciences · doi:10.1051/medsci/2023094
Güncel Biyokimya Çalışmaları VII
Atıcı, Y., Ökten, Z., Kasebi, S., Arıkan, B. S., Erdem, M., Kıran, T. R., Yağız, A. K., Aktolun, B., Demirağcı, Y. G., Kara, H., et al. (2024) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3109
Potential Effects of Antiaging Compounds: Implications on Brain Aging
Abinaya, G. P., Iyshwarya, B. K., & Veerabathiran, R. (2024) · Springer eBooks · doi:10.1007/978-981-99-7269-2_9
Computational Prediction for Precision Drug Discovery Against LRRK2 and GBA in Parkinson’s Disease
Brinda, M., Reddy, R. M. R., Durwas, S. G., Ananthaswamy, S., Shenoy, R. S., & Bhat, S. (2024) · Learning and analytics in intelligent systems · doi:10.1007/978-3-031-65392-6_20 · Cited by 1
Bikri, S., Aboussaleh, Y., & Fouad, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00011-7 · Cited by 1
Jawad, M. J., Uthirapathy, S., Altalbawy, F. M. A., Oghenemaro, E. F., Rizaev, J. A., Lal, M., Eldesoqui, M. B., Sharma, N., Pramanik, A., & AL-Hamairy, A. K. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01622-9 · Cited by 8
“Through disruption of the metal ion balance, resveratrol mitigates this (Gomes et al. 2018).”
Common Signaling Pathways in Cancer and Alzheimer's Disease May Point to New Treatments
Wu, C., Jiang, L., Zhong, Y., & Liu, Z. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266340314250303003647
Alzheimer's disease – An overview of nano herbal formulations
Patil, V. S., Patil, S., Patil, S. R., Pawar, A. S., & Shete, A. S. (2025) · Pharmacological Research - Reports · doi:10.1016/j.prerep.2025.100042
Ma, Z., Li, H., He, Z., Wang, L., He, J., Qian, Y., & Kang, J.-C. (2025) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2025.2502611
Exploring the role of plants as neuroprotectant and its mode of action
Thakur, A., Samayak, Shukla, M. K., Sharma, S., Kumar, S., Husain, A., & Kumar, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00045-0 · Cited by 1
Xia, X., Xiong, Y., Liao, Y., & Wang, J. (2025) · Pharmacognosy Magazine · doi:10.1177/09731296251365468
“The neuroprotective effect of RV has been confirmed, but it may also attack non-SIRT1 to take part in biological activity (Gomes et al., 2018; Maugeri et al., 2018; Sarubbo et al., 2018; Zhang et al., 2019).”
Wang, Y., Jia, J., Li, B., Lv, G., & Chen, S. (2025) · Aging advances. · doi:10.4103/agingadv.agingadv-d-25-00025 · Cited by 2
Caloric Restriction Mimetics and Their Neuroprotective Potential
Garg, G., Singh, I., Prabhu, P., & Jain, V. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2790-8_4
Inflammation and Brain Ageing: Anti-inflammatory Nutraceuticals
Kaushik, M., Parameshwar, K., Rajput, D., Pamu, S., & Potdar, M. B. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2790-8_6 · Cited by 1
Antioxidants as immunomodulators for Tau and Amyloid-β in Alzheimer’s disease
Chinnathambi, S., Rangappa, N., & Chandrashekar, M. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.007
Wan, C., Liu, X.-Q., Chen, M., Ma, H.-H., Wu, G.-L., Qiao, L.-J., Cai, Y.-F., & Zhang, S. (2024) · Figshare · doi:10.6084/m9.figshare.26562958
Deyell, J., Hasselmann, J., Stroud, L., Raychaudhuri, U., Guo, Y., Cha, B., Karma, C., Tendean, D., Tran, M.-H. V., Gromova, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.17.692628
Nourishing the Mind: Nutritional Strategies for Neurological Disorders
Kumari, M. (2026) · Springer eBooks · doi:10.1007/978-981-95-4169-0_8
Exploring Active Natural Compounds with Neuroprotective Effects Across Tree of Life
Pandey, M. K., Kumar, R., Rai, S., Kumar, A., & Sinha, R. K. (2026) · Springer eBooks · doi:10.1007/978-981-95-4169-0_5
Exploring the Efficacy of Natural Anti-inflammatory Compounds in Neurological Disorders
Samaddar, S., Redhwan, M. A. M., & Eraiah, M. M. (2026) · Springer eBooks · doi:10.1007/978-981-95-4169-0_7 · Cited by 1
Ren, Y., Hu, M., Yang, L., Pieper, A. A., Cummings, J. L., & Cheng, F. (2026) · Genome Research · doi:10.1101/gr.280436.125
“For instance, resveratrol, highlighted as a potential drug candidate in astrocytes, oligodendrocytes, and inhibitory neurons, is a polyphenolic compound found in grapes and red wine with antioxidant properties (Bastianetto et al. 2015; Jia et al. 2017; Gomes et al. 2018).”
Urganci, Ü., & Isik, F. (2025) · Analecta Technica Szegedinensia · doi:10.14232/analecta.2025.3-4.48-73
Rai, A. R., Rai, R., Joy, T., Rai, I., Rao, Y. L., Massand, A., Blossom, V., & Murlimanju, B. V. (2026) · National Journal of Clinical Anatomy · doi:10.4103/njca.njca_90_25
Hlel, H., Abidi, A., Hamdi, Y., Meftehi, A., Cherif, A., Lizard, G., Oueslati, A., Masmoudi‐Kouki, O., & Ghrairi, T. (2026) · Brain Organoid and Systems Neuroscience Journal · doi:10.34133/bosn.0001
Karmakar, A., Roycowdhury, P., Sengupta, P., & Mukhopadhyay, D. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.02.007
Waheed, A., & Mshimesh, B. A. R. (2026) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v26i1.1346
Amélioration de la régénération cellulaire et tissulaire au cours du vieillissement
Alle, Q. (2020) · theses.fr (ABES) · doi:10.70675/932e617bzcb45z4332z8badzfda37d5299a8
Sariaslani, P., Mohammadi, H., Parsa, D., Abadi, A. R. L., Rezaeian, S., & Mirzaeei, S. (2026) · Journal of Kermanshah University of Medical Sciences · doi:10.5812/jkums-170810
Visentini, A., Reichert, K. P., Schetinger, M. R. C., Bottari, N. B., Miron, V. V., Castro, M. F. V., da Silveira, M. V., Assmann, C. E., Schirmann, A. A., & Morsch, V. M. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01859-z
“Furthermore, its neuroprotective, anti-amyloidogenic, and antifibrillary effects have been reported (Gomes et al. 2018).”
Natural products in neurodegenerative diseases: role of serine/threonine kinases
Ahmed, L. A., Ahmed, M. K., Sayed, N. S. E., & Farag, M. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44173-8.00023-1
Ren, K., Abolhassani, A., Boycott, C., Zhang, J., Zhang, H. A., Khan, A., & Stefanska, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-29192-0.00071-6
Jiang, Q., & Yan-Jiang, W. A. N. G. (2026) · Shengming kexue · doi:10.3724/cbls.2026100
Epigenetic modulators as therapeutics for neurodegenerative disorders/Alzheimer’s disease
Halder, D., Prajapati, D., Banerjee, T., Biswas, S., & Ghosh, B. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.06.010
Biochemical modulators of synaptic plasticity: New horizons in Alzheimer's disease treatment
Farzeen, I., Nazir, M. M., Jaan, Z., Ghaffar, W., Masood, A., YASMEEN, M., Ashraf, A., & Różański, H. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261469864
Saffour, S., Gül, T. S., & Gul, H. I. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2714022
Liu, L., & Zhao, Y. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1850414
Cheng, S., Zhang, J., Fu, Q., Xue, L., Mu, Y., Ren, H., & Liu, J. (2026) · Aquaculture Research · doi:10.1155/are/8361909
Neurotrophins as novel nutraceutical strategies for neurological complications: a review
Anamika, & Budhiraja, T. (2026) · Proceedings of the Indian National Science Academy · doi:10.1007/s43538-026-00883-y
Hippocampal atrophy and its consequences in AD
Memudu, A. E., Ovwere, I. R., Funsho, I. I., Nwanama, K. E., Ighodaro, C. N., & Noufal, A. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.028
El-Sawah, R. M., Abou-El-Naga, A. M., Ashry, N. I., & El-Ghaweet, H. A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06167-2
“RES has promising therapeutic potential against neurodegenerative diseases [9].”
Contribution of Fruits to Food Security in Saudi Arabia
Mahmoud, H. H., Ahmed, A. E., Alturki, S. M., & Ali-Dinar, H. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-32800-7_16
Transcriptomics-guided mechanistic mapping of phytotherapeutics for alzheimer’s disease
Veerasamy, T., & Sundaresan, N. (2026) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2026.100883
窦报敏, Chen, J., Zhao, H., Sun-Yan, A., Zhu, X., & Xu, Y. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109130
Kumar, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02417-w
Metadata
- Authors
- Gomes, B. A. Q., Silva, J. P. B., Romeiro, C. F. R., dos Santos, S. M., Rodrigues, C. A., Gonçalves, P. R., Sakai, J. T., Mendes, P. F. S., Varela, E. L. P., & Monteiro, M. C.
- Affiliations
- Universidade Federal do Pará (BR)
- Corresponding author
- Monteiro, Marta Chagas
- ORCID
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2018-01
- Volume
- 2018
- Issue
- 1
- Pages
- 8152373-8152373
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC6232815
- OpenAlex
- W2898838755
- Cited by
- 403
- References
- 170
- Citations by year
- 2026: 40 · 2025: 52 · 2024: 52 · 2023: 58 · 2022: 58 · 2021: 54 · 2020: 64 · 2019: 24
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Amazônia Paraense de Amparo à Pesquisa
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- resveratrol, Alzheimer's disease, SIRT1, neuroprotection, amyloid-beta aggregation, antioxidant activity, anti-inflammatory activity, microglial activation, M1 microglia, Th2 immune response, p53 deacetylation, neuronal apoptosis, neurogenesis, hippocampus
- MeSH terms
- Resveratrol, Alzheimer Disease, Animals, Antioxidants, Humans, Neuroprotective Agents, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.